Publication:

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial

Date

Date

Date
2023
Journal Article
Published version

Citations

Citation copied

Frey, M., Smigielski, L., Tini, E., Fekete, S., Fleischhaker, C., Wewetzer, C., Karwautz, A., Correll, C. U., Gerlach, M., Taurines, R., Plener, P. L., Malzahn, U., Kornbichler, S., Weninger, L., Brockhaus, M., Reuter-Dang, S.-Y., Reitzle, K., Rock, H., Imgart, H., … Egberts, K. M. (2023). Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial. Pharmaceutics, 15(9), 2202. https://doi.org/10.3390/pharmaceutics15092202

Abstract

Abstract

Abstract

Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range in this age group. Within a large naturalistic observational prospective multicenter clinical trial (“TDM-VIGIL”), a transdiagnostic sample of children and adolescents (n = 138; mean age, 15; range, 7–18 years; 24.6% males) was treated with fluoxetine (10–40 mg/day). Analyses of both the la

Metrics

Downloads

74 since deposited on 2023-10-10
Acq. date: 2025-11-09

Views

71 since deposited on 2023-10-10
Acq. date: 2025-11-09

Additional indexing

Creators (Authors)

  • Frey, Michael
    affiliation.icon.alt
  • Smigielski, Lukasz
    affiliation.icon.alt
  • Tini, Elvira
    affiliation.icon.alt
  • Fekete, Stefanie
    affiliation.icon.alt
  • Fleischhaker, Christian
    affiliation.icon.alt
  • Wewetzer, Christoph
    affiliation.icon.alt
  • Karwautz, Andreas
    affiliation.icon.alt
  • Correll, Christoph U
    affiliation.icon.alt
  • Gerlach, Manfred
    affiliation.icon.alt
  • Taurines, Regina
    affiliation.icon.alt
  • Plener, Paul L
    affiliation.icon.alt
  • Malzahn, Uwe
    affiliation.icon.alt
  • Kornbichler, Selina
    affiliation.icon.alt
  • Weninger, Laura
    affiliation.icon.alt
  • Brockhaus, Matthias
    affiliation.icon.alt
  • Reuter-Dang, Su-Yin
    affiliation.icon.alt
  • Reitzle, Karl
    affiliation.icon.alt
  • Rock, Hans
    affiliation.icon.alt
  • Imgart, Hartmut
    affiliation.icon.alt
  • Heuschmann, Peter
    affiliation.icon.alt
  • Unterecker, Stefan
    affiliation.icon.alt
  • Briegel, Wolfgang
    affiliation.icon.alt
  • Banaschewski, Tobias
    affiliation.icon.alt
  • Fegert, Jörg M
    affiliation.icon.alt
  • Hellenschmidt, Tobias
    affiliation.icon.alt
  • Kaess, Michael
    affiliation.icon.alt
  • Kölch, Michael
    affiliation.icon.alt
  • Renner, Tobias
    affiliation.icon.alt
  • Rexroth, Christian
    affiliation.icon.alt
  • Walitza, Susanne
    affiliation.icon.alt
  • Schulte-Körne, Gerd
    affiliation.icon.alt
  • Romanos, Marcel
    affiliation.icon.alt
  • Egberts, Karin M
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
15

Number

Number

Number
9

Page range/Item number

Page range/Item number

Page range/Item number
2202

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Keywords

TDM, adolescents, antidepressants, depression, pharmacovigilance, reference range, selective serotonin reuptake inhibitors, steady-state concentration.

Language

Language

Language
English

Publication date

Publication date

Publication date
2023-08-25

Date available

Date available

Date available
2023-10-10

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1999-4923

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

74 since deposited on 2023-10-10
Acq. date: 2025-11-09

Views

71 since deposited on 2023-10-10
Acq. date: 2025-11-09

Citations

Citation copied

Frey, M., Smigielski, L., Tini, E., Fekete, S., Fleischhaker, C., Wewetzer, C., Karwautz, A., Correll, C. U., Gerlach, M., Taurines, R., Plener, P. L., Malzahn, U., Kornbichler, S., Weninger, L., Brockhaus, M., Reuter-Dang, S.-Y., Reitzle, K., Rock, H., Imgart, H., … Egberts, K. M. (2023). Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial. Pharmaceutics, 15(9), 2202. https://doi.org/10.3390/pharmaceutics15092202

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image